Rationale: We previously showed that transgenic mice expressing Ca 2؉ /calmodulin-dependent protein kinase II ␦ C (CaMKII-TG) develop dilated cardiomyopathy associated with increased ryanodine receptors (RyR2) phosphorylation, enhanced sarcoplasmic reticulum (SR) Ca 2؉ leak and lowering of SR Ca 2؉ load. We hypothesized that phospholamban (PLN) ablation would restore SR Ca 2؉ load and prevent the decreased ventricular contractility, dilation and mortality seen in CaMKII-TG. Objective: Our objectives were to generate CaMKII-TG mice lacking PLN, determine whether the maladaptive effects of cardiac CaMKII␦ C expression were corrected, and establish the mechanistic basis for these changes.
C a 2ϩ is a critical second messenger in cardiac function. The Ca 2ϩ /calmodulin-dependent protein kinase (CaMK)II is regulated by and involved in control of Ca 2ϩ cycling in the myocardium. Several years ago we generated transgenic mice expressing CaMKII␦, the predominant cardiac CaMKII isoform. Mice expressing the CaMKII␦ C splice variant in the myocardium (CaMKII-TG) develop heart failure (HF) associated with ventricular dilation, marked decreases in fractional shortening, and mortality. 1 We established that there was increased phosphorylation of the cardiac ryanodine receptor (RyR2) at the CaMKII site, associated with increased sarcoplasmic reticulum (SR) Ca 2ϩ spark frequency and increased diastolic SR Ca 2ϩ leak. More recently we generated CaMKII␦ knockout mice and further demonstrated that HF induced by pressure overload was dependent on CaMKII␦-mediated RyR2 phosphorylation and increased Ca 2ϩ sparks. 2 The increased diastolic Ca 2ϩ leak seen in the CaMKII-TG resulted in profound SR Ca 2ϩ depletion and reduced Ca 2ϩ transients and contractions. Accordingly, we hypothesized that diminished SR Ca 2ϩ load could be responsible for the decreased contractile function and concomitant morbidity that characterized these mice. Cardiac SR Ca 2ϩ uptake is regulated through the interaction of phospholamban (PLN) with the SR Ca 2ϩ ATPase (SERCA2a). 3 PLN knockout mice (PLN-KO) exhibit enhanced myocardial contractility, 4 which can be explained by the increased SERCA2a pump activity and higher SR Ca 2ϩ load in cardiomyocytes isolated from these mice. 5 PLN ablation was shown to rescue both the functional and structural cardiomyopathy seen in mice in which the muscle LIM protein is genetically deleted. 6 Rescue of this genetic model of dilated cardiomyopathy and HF led to the proposal that ablation or inhibition of PLN would have therapeutic value in treatment of HF of various etiologies. Subsequently PLN-KO was shown to rescue cardiac hypertrophy and ventricular dysfunction in calsequestrin-and ␤ 1 -adrenergic receptor-overexpressing mice. 7, 8 In light of the cellular changes observed in the CaMKII-TG mice, in particular the prominent SR Ca 2ϩ depletion, we postulated that cardiac dysfunction would be improved if SR Ca 2ϩ was normalized by PLN ablation.
Experiments reported here examined the effects of crossing CaMKII-TG 1 with PLN-KO mice. 4 Our studies demonstrated the desired and predicted effect of PLN ablation on SR Ca 2ϩ , eg, complete rescue of the SR Ca 2ϩ depletion seen in the CaMKII-TG. Additionally, contractile function of isolated myocytes (as reflected by Ca 2ϩ transients) was improved. Unexpectedly, however, rather than improving the in vivo HF phenotype, the PLN-KO/CaMKII-TG (KO/TG) crosses showed exaggerated HF, with a more rapid onset of lethality and further decreases in contractile function.
The basis for the exaggerated HF phenotype, observed in the absence of changes in other Ca 2ϩ handling proteins, is examined in the studies presented here. The data demonstrate that in KO/TG myocytes there are greater increases in SR Ca 2ϩ sparks and leak, reflective of the now combined effects of increased SR Ca 2ϩ load and RyR2 phosphorylation. Cardiomyocyte apoptosis is also increased in KO/TG. Using isolated cardiomyocytes, we observed increased mitochondrial Ca 2ϩ in KO/TG and determined that the combined effects of increased SR Ca 2ϩ release and mitochondrial Ca 2ϩ loading contribute to diminished cardiomyocyte viability. We suggest that interventions that increase SR Ca 2ϩ in the face of enhanced diastolic Ca 2ϩ leak predispose to cardiomyocyte cell death and likely other Ca 2ϩ mediated toxicities that compromise survival.
Methods

Mice
CaMKII-TG mice 1 were crossed with PLN-KO mice 4 and heterozygous PLN offspring carrying the CaMKII transgene inbred with the ones without the transgene. Four genotypes of mice including wild type (WT), PLN-KO, CaMKII-TG, and PLN ablation with CaMKII␦ C overexpression (KO/TG) were used for experiments. All mice used in the present study were of mixed gender (more male than female) at 8 weeks of age, unless otherwise noted. All procedures were performed in accordance with NIH Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee.
Ca 2؉ Measurements of Adult Mouse Ventricular Myocytes
Mouse ventricular myocytes were isolated and loaded with indo-1-AM to assess SR Ca 2ϩ content and twitch [Ca 2ϩ ] i transients, and with fluo-4-AM for SR Ca 2ϩ spark measurements as described previously. 9 Ca 2ϩ sparks were measured in intact myocytes and were evaluated as described (IDL 5.3 computer software). 9 Ca 2ϩ spark amplitudes were normalized (F/F 0 ) to fluorescence baseline (F 0 ). Duration of the Ca 2ϩ sparks was taken as the full duration above half-maximum (FDHM) and width was the full spatial size above half maximum (FWHM). A crude index of diastolic SR Ca 2ϩ leak was calculated as Ca 2ϩ spark frequency (CaSpF)ϫFDHMϫ FWHMϫamplitude. Some myocytes were preincubated for 30 minutes with a cell-permeable myristoylated CaMKII inhibitor, autocam tide-2 related inhibitory peptide II (AIP) (Calbiochem no. 189485), before measurements.
Mitochondrial Ca 2؉ Measurements of Adult Mouse Ventricular Myocyte
Mitochondrial Ca 2ϩ was measured indirectly by examining the carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP)induced increase in [Ca 2ϩ ] i in myocytes loaded with 10 mol/L fura-2-AM (Molecular Probes; 30 minutes plus 10 minutes of deesterification). Fura-2 was excited at 340Ϯ10 and 380Ϯ10 nm, and emitted fluorescence (535Ϯ20 nm) was recorded at 100 Hz. Background-subtracted ratio fluorescence (RϭF 340 /F 380 ) was converted to [Ca 2ϩ ] i using [Ca 2ϩ ] i ϭK d ␤(R-R min )/(R max ϪR). R min , R max , K d , and ␤ were determined experimentally. To assess baseline SR Ca 2ϩ content myocytes were first paced at 0.5 Hz to steady state, and 10 mmol/L caffeine was rapidly applied. After caffeine washout, myocytes were paced at 0.5 Hz to reattain the same steady state. They were then exposed to 0Na ϩ /0Ca 2ϩ /0K ϩ solution to block the Na ϩ /Ca 2ϩ exchanger (NCX) and Na ϩ /K ϩ pump and treated with 10 mol/L thapsigargin for Ϸ45 seconds to block the SERCA pump. 10 Under these conditions, when 1 mol/L FCCP is applied to abolish the mitochondrial membrane potential, mitochondrial Ca 2ϩ is released and the rise in [Ca 2ϩ ] i is indicative of mitochondrial Ca 2ϩ content. Oligomycin (1 mol/L) was included with FCCP to block rapid ATP consumption. SR Ca 2ϩ load assessed by application of 10 mmol/L caffeine at the end of the protocol showed that the SR was still well Ca 2ϩ -loaded (and subsequent relaxation and [Ca 2ϩ ] i decline) confirm that ATP was not dissipated by the protocol. The SR cannot be reloaded after this depletion, confirming the thapsigargin-dependent SR Ca 2ϩ -ATPase inhibition. 10
Transthoracic Echocardiography
Transthoracic echocardiography was performed in mice using an Agilent Technologies Sonos 5500 system with a 15 MHz transducer as described. 1 
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Western Blotting
Western blot analysis was carried out in cardiac homogenates as described previously. 1 The antibodies used for immunoblotting were as followings: rabbit anti-calsequestrin, rabbit anti-SERCA2, mouse anti-RyR, mouse anti-phospho-CaMKII (Affinity Bioreagents), rabbit Ser2809 phospho-RyR2 antibody (Badrilla, Leeds, UK), rabbit Ser2815 phospho-RyR2 antibody (a gift from A. R. Marks, Columbia University, New York), and anti-NCX (monoclonal R3F1, a gift from K. D. Philipson, University of California at Los Angeles).
TUNEL Staining
Transverse sections of mouse hearts were labeled with fluorescein-TUNEL using a kit from Roche (Lewes, UK) according to the instructions of the manufacturer. Slides were mounted with Vectashield mounting media containing DAPI to stain for the nuclei. Wheat germ agglutinin was used to stain cell membranes and cardiomyocytes identified by their centrally located nuclei. Labeled nuclei were counted to determine the apoptotic index (number of labeled nuclei/ 10 5 total myocyte nuclei).
Cell Viability Study in Adult Mouse Ventricular Myocytes
Ventricular myocytes were isolated as described previously. 11 After isolation, cells were plated for 1 hour on laminin-coated dishes in MEM-HBSS (Hanks balanced salt solutions) medium containing 5% serum. Cells were then washed, and serum-free medium added along with vehicle, 2 mol/L KN-93, 100 nmol/L ryanodine, 5 mol/L Ru-360, or 5 mol/L cyclosporin A. Using a grid marking system, 8 fields were chosen per dish and the number of rod shaped living cells was counted at various times over a 12-hour time course. At the 12-hour time point, living cells were quantitated by trypan blue exclusion.
Statistical Analysis
All data are reported as meansϮSEM. Statistical significance of differences between groups was determined using 1-way ANOVA with Tukey post hoc test. A probability value of Ͻ0.05 was considered statistically significant.
Results
SR Ca 2؉ Load and Ca 2؉ Transients in Isolated Cardiomyocytes
To determine whether PLN ablation normalized the depressed SR Ca 2ϩ load observed in the CaMKII␦ C TG mice, SR Ca 2ϩ content was assessed by quantifying caffeineinduced Ca 2ϩ transients after 1 Hz steady-state stimulation ( Figure 1A ). Consistent with our previous reports, myocytes isolated from PLN-KO showed increased SR Ca 2ϩ load, 5 whereas those from CaMKII-TG mice exhibited significantly depressed SR Ca 2ϩ load ( Figure 1A and 1B). 9 SR Ca 2ϩ load was restored to levels equivalent to those of WT mice in myocytes from the KO/TG crosses ( Figure 1A and 1B). NCX function, assessed as the rate constant of [Ca 2ϩ ] i decline (k Ca ) in the presence of caffeine, was significantly faster in CaMKII-TG versus WT as shown previously, 9 and PLN ablation did not normalize this difference in NCX function ( Figure 1C ). Twitch Ca 2ϩ transient amplitude (⌬[Ca 2ϩ ] i at 1 Hz) was also restored in KO/TG versus CaMKII-TG myocytes ( Figure 2 ). In fact, Ca 2ϩ transients in KO/TG were greater than those in WT, likely reflecting the combination of restored SR Ca 2ϩ content along with CaMKII-dependent enhancement of fractional SR Ca 2ϩ release. 9, 12 In Vivo Global Cardiac Function
To determine whether the restoration of myocyte Ca 2ϩ handling was associated with a diminished hypertrophic/HF phenotype and improved hemodynamic function, we measured the heart/body weight (HW/BW) ratio and assessed in vivo cardiac diameters and function by echocardiography. As reported previously, CaMKII-TG mice showed significant cardiac enlargement at 8 weeks of age as assessed by HW/BW ratio 1 ; surprisingly, the increase in HW/BW was even greater in KO/TG mice ( Figure 3A ), as was cell size (not shown). Left ventricular dilation and cardiac dysfunction were also worsened in KO/TG mice relative to CaMKII-TG, as revealed by significantly greater left ventricular end diastolic dimension, diminished factional shortening, and posterior wall thinning at 6 to 8 weeks ( Figure 3B and 3C;
Online Figure I , available in the Online Data Supplement at http://circres.ahajournals.org). Differences between KO/TG and CaMKII-TG mice were most significant at earlier stages (4 to 5 weeks), becoming less divergent at 12 to 16 weeks ( Figure 3B and 3C, lower panels; Online Figure I ).
Survival Analyses
As described previously, 1 CaMKII␦ C TG mice showed premature death. KO/TG mice demonstrated worsened mortality compared to CaMKII-TG mice, with 70% of the KO/TG mice dying by 24 weeks of age ( Figure 3D ).
Expression and Phosphorylation of Ca 2؉ Regulatory Proteins
Western blot analyses were performed to assess the expression levels of calsequestrin, SERCA2a and NCX in ventricular homogenates from CaMKII-TG and KO/TG mice. As previously reported, 9 in CaMKII-TG versus WT, we found reduced SERCA2a and elevated NCX expression but unaltered calsequestrin expression (data not shown). There were no significant differences in the expression of these major Ca 2ϩ regulatory proteins in KO/TG versus CaMKII-TG mice ( Figure 4A ). Phosphorylation of the RyR2, assessed using antibodies to the CaMKII phosphorylation sites (Ser2815 and Ser2809), was increased significantly, but not differentially, in CaMKII-TG and KO/TG mice ( Figure 4B ). These data indicate that the exaggerated phenotype observed in KO/TG mice is not secondary to changes in key Ca 2ϩ handling proteins or greater RyR2 phosphorylation.
SR Ca 2؉ Sparks and Ca 2؉ Leak in Isolated Cardiomyocytes
We previously demonstrated increased Ca 2ϩ spark frequency in CaMKII-TG versus WT myocytes. 9 To determine whether the enhanced SR Ca 2ϩ content seen with PLN ablation was associated with a further increase in SR Ca 2ϩ sparks and leak, Ca 2ϩ spark frequency (CaSpF), duration (FDHM), spatial width (FWHM), and amplitude were assessed. CaSpF increased dramatically in KO/TG compared to CaMKII-TG. This was entirely blocked by pretreatment with a CaMKII inhibitory peptide, AIP ( Figure 5A ), indicating that it resulted from ongoing CaMKII activity. The overall diastolic SR Ca 2ϩ leak index (CaSpFϫFDHMϫFWHMϫamplitude) was also significantly increased in KO/TG mice (7.5-fold relative to WT and 2.5-fold relative to CaMKII-TG) ( Figure 5B ). The augmented SR Ca 2ϩ sparks and leak in KO/TG crosses can be explained in terms of the combined effects of normalized SR Ca 2ϩ load in the face of enhanced RyR2 phosphorylation. Notably enhanced SR Ca 2ϩ loading, Ca 2ϩ spark frequency, and Ca 2ϩ transients are observed in KO/TG myocytes despite lower diastolic [Ca 2ϩ ] i levels measured under comparable conditions (Online Figure II) .
Apoptosis in Heart Sections
Cardiomyocyte dropout could explain why there is reduced cardiac function, ventricular thinning and worsened HF despite enhanced Ca 2ϩ transients in KO/TG myocytes. TUNEL staining was performed to assess apoptosis in paraffin sections prepared from WT, PLN-KO, CaMKII-TG, and KO/TG mice. DAPI staining and wheat germ agglutinin were used to identify cardiomyocytes (see Methods). TUNELlabeled cardiomyocyte nuclei were counted to determine the apoptotic index (number of labeled nuclei/10 5 total myocyte nuclei). As shown in Figure 6 , the number of TUNELpositive cardiomyocytes was significantly increased (Ϸ2.6 fold) in KO/TG mouse hearts compared with WT or CaMKII-TG mice.
Cell Viability Studies
The assessment of TUNEL staining captures a single time point but suggests that the viability of cardiomyocytes is compromised in the KO/TG line. To further examine cell viability, we isolated and monitored cells by morphology and trypan blue exclusion at various times (Figure 7) . To test whether CaMKII or SR Ca 2ϩ release were important in regulating cell viability, cells were pretreated with 2 mol/L KN-93 (to inhibit CaMKII) or 100 nmol/L ryanodine (to deplete SR Ca 2ϩ and prevent Ca 2ϩ sparks). WT myocytes remained viable over a 12-hour period, and survival was not appreciably altered by KN-93 or ryanodine ( Figure 7A) . In contrast, the percentage of live myocytes from both CaMKII-TG and KO/TG mice decreased dramatically over 12 hours (to less than 30%). Inhibition of CaMKII with KN-93 or of SR Ca 2ϩ leak with ryanodine decreased the rate of myocyte death in both CaMKII-TG and KO/TG mice ( Figure 7B and 7C ), suggesting that the CaMKII-mediated increase in SR Ca 2ϩ release contributes to diminished myocyte viability.
Mitochondrial Ca 2؉ in Isolated Cardiomyocytes
The dramatic increase in diastolic Ca 2ϩ sparks could increase mitochondrial Ca 2ϩ loading and thereby contribute to decreased cardiomyocyte viability. To explore this possibility, we assessed mitochondrial Ca 2ϩ content in isolated adult myocytes from WT, CaMKII-TG, or KO/TG mice as detailed in Methods ( Figure 8A) . The protocol was designed to allow mitochondrial Ca 2ϩ loading to occur during regular pulses (see initial cytosolic [Ca 2ϩ ] i transients) and a 40-second rest period where Ca 2ϩ sparks could occur. The release of mitochondrial Ca 2ϩ was then induced using FCCP, under conditions where the released Ca 2ϩ is trapped in the cytosol (SERCA, NCX, and Na ϩ /K ϩ -ATPase inhibited) and quantitated by the rise in [Ca 2ϩ ] i . Figure 8A demonstrates that the FCCP-induced rise in [Ca 2ϩ ] i in KO/TG (black trace) is substantially larger than that in WT (gray trace), reflecting a greater mitochondrial Ca 2ϩ load. Mitochondrial Ca 2ϩ load was more than 4-fold higher in KO/TG versus WT or CaMKII-TG myocytes ( Figure 8B) . To more directly test the relationship between Ca 2ϩ sparks and mitochondrial Ca 2ϩ loading in KO/TG myocytes, external Ca 2ϩ was reduced (to 0.3 mmol/L) and CaMKII was inhibited (with AIP). This restored SR Ca 2ϩ content and Ca 2ϩ transients ( Figure 8C ), as well as Ca 2ϩ spark frequency (not shown) in KO/TG myocytes to near WT levels. Strikingly, mitochondrial Ca 2ϩ was not increased in KO/TG myocytes under these conditions ( Figure 8B) .
The role of mitochondrial Ca 2ϩ overloading in myocyte viability was examined by treating cells with an inhibitor of the mitochondrial uniporter (Ru-360) or the mitochondrial permeability transition (PT)-pore (cyclosporin A). Both agents significantly enhanced survival of KO/TG cardiomyocytes ( Figure 8D ), implicating mitochondrial Ca 2ϩ overloading and the PT-pore in the diminished viability of these versus WT cells. On the other hand, neither agent increased the survival of CaMKII-TG myocytes ( Figure 8D ), suggesting that mitochondrial Ca 2ϩ overloading is less critical to the viability of the CaMKII-TG cells.
Discussion
PLN As a Target for HF Treatment
The SR Ca 2ϩ content of cardiomyocytes is a key determinant of SR Ca 2ϩ release and resultant Ca 2ϩ transients. 13 SR Ca 2ϩ uptake is decreased in many animal models of HF and human failing heart, and this has been suggested to cause contractile dysfunction by decreasing the stored Ca 2ϩ available for release. Ca 2ϩ uptake into the SR is mediated by the SR Ca 2ϩ ATPase (SERCA2a) and regulated by PLN, an endogenous inhibitor of SERCA2a whose activity is regulated by phosphorylation. Ablation or inhibition of PLN has been proposed as a viable therapeutic strategy for treating HF by restoring SR Ca 2ϩ load 14, 15 ; this notion is supported by a number of reports, including the rescue of cardiomyopathy and HF in muscle LIM protein KO 6 and calsequestrin or ␤ 1 transgenic mice 7, 8 and the suppression of HF progression in cardiomyopathic hamsters 16 and in rats following myocardial infarction. 17 In sharp contrast, in the present study, as in several other genetic hypertrophy and HF models, 18, 19 PLN ablation clearly restored myocyte Ca 2ϩ stores, Ca 2ϩ transients and contraction, but failed to rescue in vivo cardiac function or the HF phenotype. Thus, although depressed SR Ca 2ϩ uptake is an important feature of HF (and a target to correct cellular Ca 2ϩ dysregulation), restoration of SR Ca 2ϩ handling does not appear to rescue all sequelae associated with HF development. The dissociation between improved cardiomyocyte SR Ca 2ϩ handling and the in vivo loss of ventricular function and survival in the KO/TG mice provided an opportunity to explore, at the cellular level, why restoring SR Ca 2ϩ content fails to improve, and indeed may worsen, global cardiac function.
Ca 2؉ , Mitochondria, and Cell Death
SR Ca 2ϩ sparks, elementary events of diastolic SR Ca 2ϩ release, have been reported to be enhanced by both CaMKII overexpression and PLN ablation. 9, 20 The CaMKII effect is primarily attributable to an activating effect on RyR2, 12 whereas PLN-KO enhances Ca 2ϩ sparks indirectly by increasing SR Ca 2ϩ content, further enhancing RyR2 opening resulting from a regulatory effect of intra-SR [Ca 2ϩ ]. 12, 21 Here, we demonstrate that SR Ca 2ϩ sparks are massively increased in the KO/TG myocytes because of the combination of CaMKII mediated RyR2 phosphorylation and elevated SR Ca 2ϩ load.
Numerous studies have demonstrated that mitochondrial Ca 2ϩ overload results in opening of the permeability transition (PT)-pore and that this leads to either apoptotic or necrotic cell death in various cell types including cardiomyocytes. [22] [23] [24] [25] [26] [27] Cardiomyocyte loss by apoptosis has been recognized as a major factor contributing to HF development. 28, 29 Necrosis also contributes to ventricular remodeling induced by ischemic damage or in HF. 29 -31 Enhancement of cardiomyocyte Ca 2ϩ influx, as observed in transgenic mice expressing the sarcolemmal L-type Ca 2ϩ channel, is one mechanism for eliciting Ca 2ϩ overload, mitochondrial PT-pore opening and necrotic myocyte death. 32 Mitochondria take up cytosolic Ca 2ϩ via a Ca 2ϩ -uniporter and a close relationship between SR and mitochondria, in which Ca 2ϩ released from the SR is efficiently transmitted to the mitochondria in cardiomyocytes, has been reported. 33 We suggest that the dramatic increase in Ca 2ϩ sparks in the KO/TG myocyte leads, either directly or indirectly, to increased mitochondrial Ca 2ϩ loading, PT-pore opening, and subsequent cardiomyocyte loss. This mechanism is supported by data demonstrating that mitochondrial Ca 2ϩ loading and cell death are diminished following inhibition of Ca 2ϩ sparks or mitochondrial Ca 2ϩ uptake. Loss of functional cardiomyocytes could explain why the KO/TG hearts perform more poorly than the CaMKII-TG heart, despite improved cardiomyocyte Ca 2ϩ transients.
Sympathetic Tone, CaMKII, and HF
In HF, there is typically increased sympathetic tone and PKA activation, 34 as well as increased expression and activation of CaMKII 34 -37 and enhanced RyR2 phosphorylation and SR Ca 2ϩ leak. 34, 38 Under these conditions, where phosphorylated RyR2 may already enhance diastolic SR Ca 2ϩ release, increased adrenergic signaling or therapeutic attempts to replete SR Ca 2ϩ stores could exacerbate increased SR Ca 2ϩ leak (as with PLN ablation). As suggested above, the increased leak could trigger mitochondrial Ca 2ϩ overloading with concomitant cardiomyocyte death. 27, 32 This may also help to explain data demonstrating that CaMKII activation contributes to cardiomyocyte cell death induced by ␤-adrenergic stimulation and to isoproterenol-induced apoptosis or cardiomyopathy in vivo. 39 -41 Increased SR Ca 2ϩ leak induced by concomitant increases in SR Ca 2ϩ content and RyR2 phosphorylation could also predispose to arrhythmias, a possible basis for the observed increase in mortality in the KO/TG mice. Although arrhythmias may not occur in all forms of HF in which SERCA function is restored, 42 arrhythmias are seen in the CaMKII-TG. 43 The notion that arrhythmias would be enhanced by the increased Ca 2ϩ leak 44, 45 is further supported by our recent demonstration that isoproterenol treatment is highly arrhythmogenic in CaMKII-TG myocytes in vitro and in vivo. 46 In conclusion, enhanced SR Ca 2ϩ uptake via PLN ablation can improve myocyte Ca 2ϩ transients in transgenic mice that develop CaMKII-mediated heart failure. However, the enhanced SR Ca 2ϩ content exacerbates the already high level of diastolic Ca 2ϩ spark activity, which could increase arrhythmias and further worsen overall heart function (via mitochondrial Ca 2ϩ loading and cell death). The data are consistent with the working hypothesis that in the face of phosphorylated activated RyR2 channels, repletion of Ca 2ϩ stores through PLN ablation (or during sympathetic activation) can exacerbate SR Ca 2ϩ leak and thereby increase mitochondrial Ca 2ϩ -mediated cell death or activate other Ca 2ϩ -dependent processes that contribute to cardiac dysfunction.
